Nakanishi K, Takamura Y, Nakano Y, Inatani M, Oki M
Genes Cells. 2025; 30(2):e13196.
PMID: 39916601
PMC: 11803434.
DOI: 10.1111/gtc.13196.
Cunha Ferreira C, Machado Soares R, Fernandes J, Teixeira S, Saraiva E, Ribeiro L
J Ophthalmic Vis Res. 2024; 19(3):324-333.
PMID: 39359524
PMC: 11443993.
DOI: 10.18502/jovr.v19i3.13531.
Neo T, Gozawa M, Takamura Y, Inatani M, Oki M
PLoS One. 2020; 15(7):e0236928.
PMID: 32735610
PMC: 7394371.
DOI: 10.1371/journal.pone.0236928.
Shalchi Z, Mahroo O, Bunce C, Mitry D
Cochrane Database Syst Rev. 2020; 7:CD009510.
PMID: 32633861
PMC: 7388176.
DOI: 10.1002/14651858.CD009510.pub3.
Terashima H, Hasebe H, Okamoto F, Matsuoka N, Sato Y, Fukuchi T
Retina. 2018; 39(7):1377-1384.
PMID: 29689025
PMC: 6613833.
DOI: 10.1097/IAE.0000000000002165.
Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2.
Narayanan R, Panchal B, Stewart M, Das T, Chhablani J, Jalali S
Clin Ophthalmol. 2016; 10:1023-9.
PMID: 27330272
PMC: 4898411.
DOI: 10.2147/OPTH.S104459.
Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.
Shirakata Y, Fukuda K, Fujita T, Nakano Y, Nomoto H, Yamaji H
Clin Ophthalmol. 2016; 10:277-83.
PMID: 26917950
PMC: 4751895.
DOI: 10.2147/OPTH.S85751.
Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis.
Sun Y, Qu Y
Int J Ophthalmol. 2015; 8(6):1234-9.
PMID: 26682180
PMC: 4651896.
DOI: 10.3980/j.issn.2222-3959.2015.06.29.
Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
Chiquet C, Dupuy C, Bron A, Aptel F, Straub M, Isaico R
Graefes Arch Clin Exp Ophthalmol. 2015; 253(12):2095-102.
PMID: 25673251
DOI: 10.1007/s00417-015-2947-9.
Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
Battaglia Parodi M, Iacono P, Bandello F
Graefes Arch Clin Exp Ophthalmol. 2014; 253(10):1647-51.
PMID: 25382074
DOI: 10.1007/s00417-014-2845-6.
Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study.
Sakimoto S, Kamei M, Sakaguchi H, Suzuki M, Matsumura N, Nishida K
Clin Ophthalmol. 2014; 8:2055-60.
PMID: 25336905
PMC: 4199790.
DOI: 10.2147/OPTH.S66878.
A clinical study to evaluate the efficacy of intravitreal Anti-VEGF therapy in treating macular edema due to retinal venous occlusions.
Kumar P, Banarji A, Patyal S, Gurunadh V, Ahluwalia T, Oli A
Med J Armed Forces India. 2014; 69(3):260-7.
PMID: 24600120
PMC: 3862666.
DOI: 10.1016/j.mjafi.2013.02.001.
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.
Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K
Br J Ophthalmol. 2013; 98(2):195-9.
PMID: 24215032
PMC: 3913112.
DOI: 10.1136/bjophthalmol-2013-303121.
Early Avastin management in acute retinal vein occlusion.
Mehany S, Mourad K, Shawkat A, Sayed M
Saudi J Ophthalmol. 2013; 24(3):87-94.
PMID: 23960882
PMC: 3729706.
DOI: 10.1016/j.sjopt.2010.03.004.
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.
Yunoki T, Mitarai K, Yanagisawa S, Kato T, Ishida N, Hayashi A
J Ophthalmol. 2013; 2013:415974.
PMID: 23533707
PMC: 3590779.
DOI: 10.1155/2013/415974.
Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α.
Yang J, Caldwell R, Behzadian M
Exp Eye Res. 2012; 100:101-8.
PMID: 22564969
PMC: 3798053.
DOI: 10.1016/j.exer.2012.03.011.
Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.
Yilmaz T, Cordero-Coma M
Graefes Arch Clin Exp Ophthalmol. 2012; 250(6):787-93.
PMID: 22539192
DOI: 10.1007/s00417-012-2016-6.
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
Ramezani A, Esfandiari H, Entezari M, Moradian S, Soheilian M, Dehsarvi B
Graefes Arch Clin Exp Ophthalmol. 2012; 250(8):1149-60.
PMID: 22331147
DOI: 10.1007/s00417-012-1941-8.
Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.
Yunoki T, Miyakoshi A, Nakamura T, Fujita K, Fuchizawa C, Hayashi A
Jpn J Ophthalmol. 2012; 56(2):159-64.
PMID: 22246387
DOI: 10.1007/s10384-011-0114-3.
Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.
Hanada N, Iijima H, Sakurada Y, Imasawa M
Jpn J Ophthalmol. 2011; 56(2):165-74.
PMID: 22183139
DOI: 10.1007/s10384-011-0113-4.
